Icodextrine and Insulin Resistance in Continuous Ambulatory Peritoneal Dialysis Patients

REFERENCES

• Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998; 53: 1343–1347
   PubMed Web of Science ®Google Scholar
• Stout RW. Diabetes and atherosclerosis—the role of insulin. Diabetologia. 1979; 16: 141–148
   PubMed Web of Science ®Google Scholar
• Moorhead JF, Chan MK, Varghase Z. The role of abnormalities of lipid metabolism in the progression of renal disease. The Progressive Nature of Renal Disease, BM Brenner, JH Stein. Churchill Livingstone, New York, NY 1986; 133–149
   Google Scholar
• Ikeda T, Gomi T, Hirawa N, Sakurai J, Yoshikawa N. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension. 1996; 27: 1180–1186
   PubMed Web of Science ®Google Scholar
• Mak RHK, De Fronzo RA. Glucose and insulin metabolism in uremia. Nephron. 1992; 61: 377–382
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest. 1981; 67: 563–570
   PubMed Web of Science ®Google Scholar
• Mak RHK. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol. 1996; 270: F839–844
   PubMed Web of Science ®Google Scholar
• Mak RHK. Metabolic effects of erythropoietin in patients on peritoneal dialysis. Pediatr Nephrol. 1998; 12: 660–665
   PubMed Web of Science ®Google Scholar
• Mak RHK, Turner C, Thompson T, Haycock GB, Chantler C. The effect of dietary protein restriction and amino acid / keto acid suplements on glucose metabolism in uremic patients. J Clin Endocrinol Metab. 1986; 63: 985–989
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Beckles AD. Glucose intolerance following chronic metabolic acidosis in man. Am J Physiol. 1979; 236: E328–E334
   PubMedGoogle Scholar
• Hernandez C, Genesca J, Ignasi Esteban J, Garcia L, Simo R. Relationship between iron stores infected by hepatitis C virus: A case-control study. Med Clin (Barc). Jun 3, 2000; 115(1)21–22
   PubMed Web of Science ®Google Scholar
• Yıldız A, Tutuncu Y, Yazıcı H, Akkaya V, Kayacan SM, Sever MS, et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellutus in renal transplant recipient. Transplantation. Oct 27, 2000; 74(8)1109–1113
   Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Rowe JW, Anders R. Glucose intolerance in uremia: quantification of pancreatic beta cell to glucose and tissue sensitivity to insulin. J Clin Invest. 1978; 62: 425–435
   PubMed Web of Science ®Google Scholar
• Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyper osmolar glucose solutions in CAPD. Midas study group. Multicenter investigation of icodextrin in ambulatory peritoneal dialysis. Kidney Int. 1994; 46: 496–503
   PubMed Web of Science ®Google Scholar
• Brown CB, Gokal R, Mistry CD. Scientific Symposium on Icodextrın in ID, December 1993 London UK. Perit Dial Int. 1994; 14(Suppl 2)
   PubMedGoogle Scholar
• Feldman HA, Singer I. Endocrinology and metabolism in uremia and dialysis: a clinical rewiev. Medicine. 1974; 54: 345–376
   Web of Science ®Google Scholar
• Linder A, Charra B, Sherpard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974; 290: 697–701
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Maejima S, Ikeda T, Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2000; 15: 65–70
   PubMed Web of Science ®Google Scholar
• Delarue J, Maingourd C, Couet C, Vidal S, Bagros P, Lamisse F. Effects of oral glucose on intermediary metabolism in continous ambulatory peritoneal dialysis patients versus healthy subjects. Peritoneal Dial Int. 1998; 18: 505–511
   PubMed Web of Science ®Google Scholar
• Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinsm reduction associated with icodextrin treatment in continous ambulatory peritoneal dialysis patients. Adv Perit Dial. 2001; 17: 80–83
   PubMedGoogle Scholar
• Sisca S, Maggiore U. Benefical effect of icodextrin on the hypertriglyceridemia of CAPD patients. Perit Dial Int. 2002; 22: 727–729
   PubMed Web of Science ®Google Scholar
• Mak RHK. 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int. 1992; 41: 1048–1054
   Web of Science ®Google Scholar
• Borissova AM, Djambazova A, Todorov K, Dakovska L, Tankova T, Kirilov G. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on hemodialysis. Nephrol Dial Transplant. 1993; 8: 93–95
   PubMed Web of Science ®Google Scholar
• Kokot F, Wiecek A, Grzeszczak W. Influence of erythropoietin treatment on endocrine abnormalities in hemodialyzed patients. Erythropoietin: From Molecular Structure to Clinical Application, CA Baldamus, KM Koch, P Scigalla, L Wieczorek. Karger, Basel 1990; 257–272
   Google Scholar
• Fadda GZ, Tanakitcharu P, Smogorzewski M, Massry SG. Parathyroid hormone raises citosolic calcium in pancreatic islets: study on mechanisms. Kidney Int. 1993; 43: 554–560
   PubMed Web of Science ®Google Scholar
• Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int. 1994; 46: 496–503
   PubMed Web of Science ®Google Scholar
• Lindholm B, Bergstrom J. Nutritional aspects of CAPD. Continous Ambulatory Peritoneal Dialysis, R Gokal. Churchill Livingstone, Edinburgh 1985; 228–264
   Google Scholar
• Holmes C, Shockley T. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000; 20(Suppl. 2)37–41
   Google Scholar